Inovio Pharmaceuticals Inc
About
Inovio Pharmaceuticals Inc (NASDAQ:INO) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 2 2026
INOVIO Announces Pricing of $17.5 Million Public Offering
Apr 1 2026
INOVIO to Participate in Upcoming Scientific Conference
Mar 12 2026
INOVIO Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
Mar 5 2026
INOVIO to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026
Mar 4 2026
Akeso and INOVIO Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM)
Financials
Revenue
$65.34 K
Market Cap
$78.07 M
EPS
-1.81